Exo secures $200M toward commercializing ultrasound device

Exo secures $200M toward commercializing ultrasound device

Exo, pronounced “echo,” raised a fresh cash infusion of $220 million in Series C financing aimed at commercializing its handheld ultrasound device and point-of-care workflow platform, Exo Works. The round was led by RA Capital Management, while BlackRock, Sands...